Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DDSA Pharmaceuticals is a London-based pharmaceutical company that specializes in the manufacture and supply of generic prescription drugs. Established in 1961, the company focuses on providing a range of essential medicines to the UK market, particularly within the fields of psychiatry and neurology. Its product portfolio includes well-known generic treatments such as chlordiazepoxide and diazepam. DDSA operates as a private entity, maintaining its own manufacturing and distribution capabilities to serve healthcare providers and the National Health Service (NHS). The firm is recognized for its long-standing role in the supply chain of essential generic pharmaceuticals in the United Kingdom.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DDSA Pharmaceuticals.